265 related articles for article (PubMed ID: 22245898)
21. Inflammatory pathways and cholangiocarcinoma risk mechanisms and prevention.
Cadamuro M; Strazzabosco M
Adv Cancer Res; 2022; 156():39-73. PubMed ID: 35961707
[TBL] [Abstract][Full Text] [Related]
22. Pathogenesis of Choledochal Cyst: Insights from Genomics and Transcriptomics.
Ye Y; Lui VCH; Tam PKH
Genes (Basel); 2022 Jun; 13(6):. PubMed ID: 35741793
[TBL] [Abstract][Full Text] [Related]
23. Activation of the Unfolded Protein Response (UPR) Is Associated with Cholangiocellular Injury, Fibrosis and Carcinogenesis in an Experimental Model of Fibropolycystic Liver Disease.
Chen C; Wu H; Ye H; Tortajada A; Rodríguez-Perales S; Torres-Ruiz R; Vidal A; Peligros MI; Reissing J; Bruns T; Mohamed MR; Zheng K; Lujambio A; Iraburu MJ; Colyn L; Latasa MU; Arechederra M; Fernández-Barrena MG; Berasain C; Vaquero J; Bañares R; Nelson LJ; Trautwein C; Davis RJ; Martinez-Naves E; Nevzorova YA; Villanueva A; Avila MA; Cubero FJ
Cancers (Basel); 2021 Dec; 14(1):. PubMed ID: 35008241
[TBL] [Abstract][Full Text] [Related]
24. Senescence markers in focal nodular hyperplasia of the liver: pathogenic considerations on the basis of immunohistochemical results.
Denk H; Pabst D; Abuja PM; Reihs R; Tessaro B; Zatloukal K; Lackner C
Mod Pathol; 2022 Jan; 35(1):87-95. PubMed ID: 34645984
[TBL] [Abstract][Full Text] [Related]
25. The heterogeneity of the biliary tree.
de Jong IEM; van den Heuvel MC; Wells RG; Porte RJ
J Hepatol; 2021 Nov; 75(5):1236-1238. PubMed ID: 34420805
[TBL] [Abstract][Full Text] [Related]
26. Decreased risk of liver and intrahepatic cancer in non-H. pylori-infected perforated peptic ulcer patients with truncal vagotomy: a nationwide study.
Wu SC; Cheng HT; Wang YC; Tzeng CW; Hsu CH; Muo CH
Sci Rep; 2021 Aug; 11(1):15594. PubMed ID: 34341400
[TBL] [Abstract][Full Text] [Related]
27. New insights on the role of vascular endothelial growth factor in biliary pathophysiology.
Mariotti V; Fiorotto R; Cadamuro M; Fabris L; Strazzabosco M
JHEP Rep; 2021 Jun; 3(3):100251. PubMed ID: 34151244
[TBL] [Abstract][Full Text] [Related]
28. Fibrocystic liver disease: novel concepts and translational perspectives.
Lasagni A; Cadamuro M; Morana G; Fabris L; Strazzabosco M
Transl Gastroenterol Hepatol; 2021; 6():26. PubMed ID: 33824930
[TBL] [Abstract][Full Text] [Related]
29. Hepatobiliary Organoids and Their Applications for Studies of Liver Health and Disease: Are We There Yet?
Shiota J; Samuelson LC; Razumilava N
Hepatology; 2021 Oct; 74(4):2251-2263. PubMed ID: 33638203
[TBL] [Abstract][Full Text] [Related]
30. Human Bile Contains Cholangiocyte Organoid-Initiating Cells Which Expand as Functional Cholangiocytes in Non-canonical Wnt Stimulating Conditions.
Roos FJM; Verstegen MMA; Muñoz Albarinos L; Roest HP; Poley JW; Tetteroo GWM; IJzermans JNM; van der Laan LJW
Front Cell Dev Biol; 2020; 8():630492. PubMed ID: 33634107
[TBL] [Abstract][Full Text] [Related]
31. MC-LR-induced interaction between M2 macrophage and biliary epithelial cell promotes biliary epithelial cell proliferation and migration through regulating STAT3.
Yan M; Gu S; Pan C; Chen Y; Han X
Cell Biol Toxicol; 2021 Dec; 37(6):935-949. PubMed ID: 33474710
[TBL] [Abstract][Full Text] [Related]
32. Stimulation of hepatocarcinogenesis by activated cholangiocytes via Il17a/f1 pathway in kras transgenic zebrafish model.
Helal M; Yan C; Gong Z
Sci Rep; 2021 Jan; 11(1):1372. PubMed ID: 33446803
[TBL] [Abstract][Full Text] [Related]
33. Obeticholic acid reduces biliary and hepatic matrix metalloproteinases activity in rat hepatic ischemia/reperfusion injury.
Ferrigno A; Palladini G; Di Pasqua LG; Berardo C; Richelmi P; Cadamuro M; Fabris L; Perlini S; Adorini L; Vairetti M
PLoS One; 2020; 15(9):e0238543. PubMed ID: 32911524
[TBL] [Abstract][Full Text] [Related]
34. The Emerging Role of Macrophages in Chronic Cholangiopathies Featuring Biliary Fibrosis: An Attractive Therapeutic Target for Orphan Diseases.
Cadamuro M; Girardi N; Gores GJ; Strazzabosco M; Fabris L
Front Med (Lausanne); 2020; 7():115. PubMed ID: 32373615
[TBL] [Abstract][Full Text] [Related]
35. Coordinated development of the mouse extrahepatic bile duct: Implications for neonatal susceptibility to biliary injury.
Khandekar G; Llewellyn J; Kriegermeier A; Waisbourd-Zinman O; Johnson N; Du Y; Giwa R; Liu X; Kisseleva T; Russo PA; Theise ND; Wells RG
J Hepatol; 2020 Jan; 72(1):135-145. PubMed ID: 31562906
[TBL] [Abstract][Full Text] [Related]
36. Neonatal McCune-Albright Syndrome: A Unique Syndromic Profile With an Unfavorable Outcome.
Corsi A; Cherman N; Donaldson DL; Robey PG; Collins MT; Riminucci M
JBMR Plus; 2019 Aug; 3(8):e10134. PubMed ID: 31485549
[TBL] [Abstract][Full Text] [Related]
37. Pathobiology of inherited biliary diseases: a roadmap to understand acquired liver diseases.
Fabris L; Fiorotto R; Spirli C; Cadamuro M; Mariotti V; Perugorria MJ; Banales JM; Strazzabosco M
Nat Rev Gastroenterol Hepatol; 2019 Aug; 16(8):497-511. PubMed ID: 31165788
[TBL] [Abstract][Full Text] [Related]
38. Regenerative Medicine of the Bile Duct: Beyond the Myth.
Buisson EM; Jeong J; Kim HJ; Choi D
Int J Stem Cells; 2019 Jul; 12(2):183-194. PubMed ID: 31022996
[TBL] [Abstract][Full Text] [Related]
39. Cholangiocyte pathobiology.
Banales JM; Huebert RC; Karlsen T; Strazzabosco M; LaRusso NF; Gores GJ
Nat Rev Gastroenterol Hepatol; 2019 May; 16(5):269-281. PubMed ID: 30850822
[TBL] [Abstract][Full Text] [Related]
40. Current therapies and novel approaches for biliary diseases.
Rajapaksha IG; Angus PW; Herath CB
World J Gastrointest Pathophysiol; 2019 Jan; 10(1):1-10. PubMed ID: 30622832
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
